RESUMO
Heart failure (HF) is the most rapidly growing cardiovascular condition with an estimated prevalence of >37.7 million individuals globally. HF is associated with increased mortality and morbidity and confers a substantial burden, in terms of cost and quality of life, for the individuals and the healthcare systems, highlighting thus the need for early and accurate diagnosis of HF. The accuracy of HF diagnosis, severity estimation, and prediction of adverse events has improved by the utilization of blood tests measuring biomarkers. The contribution of biomarkers for HF management is intensified by the fact that they can be measured in short time at the point-of-care. This is allowed by the development of portable analytical devices, commonly known as point-of-care testing (POCT) devices, which exploit the advancements in the area of microfluidics and nanotechnology. The aim of this review paper is to present a review of POCT devices used for the measurement of biomarkers facilitating decision making when managing HF patients. The devices are either commercially available or in the form of prototypes under development. Both blood and saliva samples are considered. The challenges concerning the implementation of POCT devices and the barriers for their adoption in clinical practice are discussed.
Assuntos
Insuficiência Cardíaca , Testes Imediatos/normas , Saliva/química , Idoso , Biomarcadores/análise , Biomarcadores/sangue , Insuficiência Cardíaca/sangue , Insuficiência Cardíaca/diagnóstico , Insuficiência Cardíaca/metabolismo , Humanos , Pessoa de Meia-Idade , Peptídeo Natriurético Encefálico/análise , Peptídeo Natriurético Encefálico/sangue , Fragmentos de Peptídeos/análise , Fragmentos de Peptídeos/sangue , Qualidade de VidaRESUMO
over the past years, technology has allowed information technology to contemplate complex events as well as complex semantic features to predict what types of "thoughts" are being conceptualized. The introduction of the neuro-robotics field allows a mix of different disciplines to inter-collate and produce actual results that could be considered outputs of a science-fiction novel 20 twenty years ago. In the present work, we attempted to present an example of how an automaton can move in an environment with obstacles, by regulating its behavior so as to allow a decision based on rewards and penalties. Examples of the robotic behavior, running on a virtual environment are presented, along with a discussion of its different possibilities expressed as a penalty function for the behavior of the robot.
Assuntos
Cadeias de Markov , Robótica , TecnologiaRESUMO
The aim of this work is to present the architecture of the KardiaSoft software, a clinical decision support tool allowing the healthcare professionals to monitor patients with heart failure by providing useful information and suggestions in terms of the estimation of the presence of heart failure (heart failure diagnosis), stratification-patient profiling, long term patient condition evaluation and therapy response monitoring. KardiaSoft is based on predictive modeling techniques that analyze data that correspond to four saliva biomarkers, measured by a point-of-care device, along with other patient's data. The KardiaSoft is designed based on the results of a user requirements elicitation process. A small clinical scale study with 135 subjects and an early clinical study with 90 subjects will take place in order to build and validate the predictive models, respectively.